Search Ontology:
ChEBI
PD169316
- Term ID
- CHEBI:93358
- Synonyms
-
- 2-(4-nitrophenyl)-4-(4-fluorophenyl)-5-(4-pyridinyl)-1H-imidazole
- 4-(4-fluorophenyl)-2-(4-nitrophenyl)-5-(4-pyridyl)-1H-imidazole
- 4-[4-(4-fluorophenyl)-2-(4-nitrophenyl)-1H-imidazol-5-yl]pyridine
- 4-[5-(4-fluorophenyl)-2-(4-nitrophenyl)-1H-imidazol-4-yl]-pyridine
- J1.342.800J
- PD 169316
- PD-169316
- Definition
- A member of the class of imidazoles that is 1H-imidazole in which the hydrogens at positions 2, 4, and 5 are replaced by 4-nitrophenyl, 4-fluorophenyl, and pyridin-4-yl groups, respectively. It is a potent inhibitor of p38 MAP kinase (IC50 = 89 nM).
- References
-
- cas:152121-53-4
- drugbank:DB17040
- hmdb:HMDB0244687
- lincs.smallmolecule:LSM-3731
- pubmed:10820206
- pubmed:11306695
- pubmed:11544639
- pubmed:12181122
- pubmed:12694807
- pubmed:14521923
- pubmed:15634764
- pubmed:18077363
- pubmed:19010935
- pubmed:22069054
- pubmed:24032631
- pubmed:25130739
- pubmed:28545002
- pubmed:28958943
- pubmed:30359932
- pubmed:30986374
- pubmed:32542535
- pubmed:34411914
- pubmed:37075613
- pubmed:38148557
- pubmed:38743735
- pubmed:39252535
- pubmed:39727341
- pubmed:39739720
- pubmed:40191451
- pubmed:40218465
- Ontology
- ChEBI ( EBI )
Phenotype
Phenotype resulting from PD169316
Phenotype where environments contain PD169316
Phenotype modified by environments containing PD169316
Phenotype affecting PD169316
Human Disease Model